Australia Botulinum Toxin Market Size & Outlook, 2026-2033
The botulinum toxin market in Australia is expected to reach a projected revenue of US$ 394.8 million by 2033. A compound annual growth rate of 10.23% is expected of Australia botulinum toxin market from 2026 to 2033.
The Australia botulinum toxin market generated a revenue of USD 182.1 million in 2025 and is expected to reach USD 394.8 million by 2033.
The Australia market is expected to grow at a CAGR of 10.23% from 2026 to 2033.
In terms of segment, type a was the largest revenue generating product in 2025.
Type A is the most lucrative product segment registering the fastest growth during the forecast period.
Botulinum toxin market data book summary
Market revenue in 2025
USD 182.1 million
Market revenue in 2033
USD 394.8 million
Growth rate
10.23% (CAGR from 2026 to 2033)
Largest segment
Type a
Fastest growing segment
Type A
Historical data
2021 - 2024
Base year
2025
Forecast period
2026 - 2033
Quantitative units
Revenue in USD million
Market segmentation
Type B, Type A
Key market players worldwide
Ipsen SA, Merz Pharma, US WorldMeds, Galderma Group AG Registered Shares, Evolus Inc, Allergan, Metabiologics, Lanzhou Institute Of Biological Products
Other key industry trends
In terms of revenue, Australia accounted for 1.4% of the global botulinum toxin market in 2025.
Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
In Asia Pacific, China botulinum toxin market is projected to lead the regional market in terms of revenue in 2033.
China is the fastest growing regional market in Asia Pacific and is projected to reach USD 2,028.3 million by 2033.
According to International Society of Aesthetic Plastic Surgery, in 2018, nearly 41,077 botulinum toxin, were performed in the country. Australia is among the top 10 countries with respect to expenditure on cosmetic procedures.
According to Victorian Cosmetic Institute, nearly USD 1 billion was spent on cosmetic procedures in 2017, with about USD 350 million spent on Botox procedures. In addition, the availability of facial injectable procedures at Fly-In-Fly-Out (FIFO) cosmetic clinics located across the country is anticipated to boost the market demand.
Nonsurgical procedures, such as anti-wrinkle treatments, microdermabrasion, and laser hair removal, are some of the most popular procedures among the Australian population, according to the Cosmetic Physicians College of Australasia (CPCA). High demand for cosmetic injectable treatment, increasing consumer spending, and the presence of advanced clinics is expected to boost the market growth.
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Botulinum Toxin Market Outlook will help companies and investors design strategic landscapes.
Type A was the largest segment with a revenue share of 108.51% in 2025.
Horizon Databook has segmented the Australia botulinum toxin market based on type b, type a covering the revenue growth of each sub-segment from 2021 to 2033.
According to International Society of Aesthetic Plastic Surgery, in 2018, nearly 41,077 botulinum toxin, were performed in the country. Australia is among the top 10 countries with respect to expenditure on cosmetic procedures.
According to Victorian Cosmetic Institute, nearly USD 1 billion was spent on cosmetic procedures in 2017, with about USD 350 million spent on Botox procedures. In addition, the availability of facial injectable procedures at Fly-In-Fly-Out (FIFO) cosmetic clinics located across the country is anticipated to boost the market demand.
Nonsurgical procedures, such as anti-wrinkle treatments, microdermabrasion, and laser hair removal, are some of the most popular procedures among the Australian population, according to the Cosmetic Physicians College of Australasia (CPCA). High demand for cosmetic injectable treatment, increasing consumer spending, and the presence of advanced clinics is expected to boost the market growth.
Australia Botulinum Toxin Market Product Outlook (Revenue, USD Million , 2021-2033)
Type A
Type B
Australia Botulinum Toxin Market Application Outlook (Revenue, USD Million , 2021-2033)
Therapeutic
Aesthetic
Australia Botulinum Toxin Market End Use Outlook (Revenue, USD Million , 2021-2033)
Hospitals
Dermatology Clinics
Spas and Cosmetic Centers
Reasons to subscribe to Botulinum Toxin Market Outlook databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Botulinum Toxin Market Outlook databook
Our clientele includes a mix of Botulinum Toxin Market Outlook companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia Botulinum Toxin Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Australia Botulinum Toxin Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Australia Botulinum Toxin Market, 2021-2033 (US$M)